Neumora Therapeutics, Inc. (NMRA)

Every official Neumora Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Neumora Therapeutics, Inc. documents

• Neumora Therapeutics, Inc. 10-K 2026NMRA 10-K 2026: annual report for fiscal 2026
• Neumora Therapeutics, Inc. 10-K 2025NMRA 10-K 2025: annual report for fiscal 2025
• Neumora Therapeutics, Inc. 10-K 2024NMRA 10-K 2024: annual report for fiscal 2024
• Neumora Therapeutics, Inc. 10-K 2023NMRA 10-K 2023: annual report for fiscal 2023
• Neumora Therapeutics, Inc. 10-K 2022NMRA 10-K 2022: annual report for fiscal 2022
• Neumora Therapeutics, Inc. 10-Q 2026NMRA 10-Q 2026: quarterly report for fiscal 2026
• Neumora Therapeutics, Inc. 10-Q 2025NMRA 10-Q 2025: quarterly report for fiscal 2025
• Neumora Therapeutics, Inc. 10-Q 2024NMRA 10-Q 2024: quarterly report for fiscal 2024
• Neumora Therapeutics, Inc. 10-Q 2023NMRA 10-Q 2023: quarterly report for fiscal 2023
• Neumora Therapeutics, Inc. 10-Q 2022NMRA 10-Q 2022: quarterly report for fiscal 2022
• Neumora Therapeutics, Inc. 8-K 2026NMRA 8-K 2026: current report for fiscal 2026
• Neumora Therapeutics, Inc. 8-K 2025NMRA 8-K 2025: current report for fiscal 2025
• Neumora Therapeutics, Inc. 8-K 2024NMRA 8-K 2024: current report for fiscal 2024
• Neumora Therapeutics, Inc. 8-K 2023NMRA 8-K 2023: current report for fiscal 2023
• Neumora Therapeutics, Inc. 8-K 2022NMRA 8-K 2022: current report for fiscal 2022
• Neumora Therapeutics, Inc. DEF 14A 2026NMRA DEF 14A 2026: proxy statement for fiscal 2026
• Neumora Therapeutics, Inc. DEF 14A 2025NMRA DEF 14A 2025: proxy statement for fiscal 2025
• Neumora Therapeutics, Inc. DEF 14A 2024NMRA DEF 14A 2024: proxy statement for fiscal 2024
• Neumora Therapeutics, Inc. DEF 14A 2023NMRA DEF 14A 2023: proxy statement for fiscal 2023
• Neumora Therapeutics, Inc. DEF 14A 2022NMRA DEF 14A 2022: proxy statement for fiscal 2022
• Neumora Therapeutics, Inc. Form 4 2026NMRA Form 4 2026: insider trading filing for fiscal 2026
• Neumora Therapeutics, Inc. Form 4 2025NMRA Form 4 2025: insider trading filing for fiscal 2025
• Neumora Therapeutics, Inc. Form 4 2024NMRA Form 4 2024: insider trading filing for fiscal 2024
• Neumora Therapeutics, Inc. Form 4 2023NMRA Form 4 2023: insider trading filing for fiscal 2023
• Neumora Therapeutics, Inc. Form 4 2022NMRA Form 4 2022: insider trading filing for fiscal 2022
• Neumora Therapeutics, Inc. S-1 2026NMRA S-1 2026: registration statement for fiscal 2026
• Neumora Therapeutics, Inc. S-1 2025NMRA S-1 2025: registration statement for fiscal 2025
• Neumora Therapeutics, Inc. S-1 2024NMRA S-1 2024: registration statement for fiscal 2024
• Neumora Therapeutics, Inc. S-1 2023NMRA S-1 2023: registration statement for fiscal 2023
• Neumora Therapeutics, Inc. S-1 2022NMRA S-1 2022: registration statement for fiscal 2022
• Neumora Therapeutics, Inc. 13F 2026NMRA 13F 2026: institutional holdings for fiscal 2026
• Neumora Therapeutics, Inc. 13F 2025NMRA 13F 2025: institutional holdings for fiscal 2025
• Neumora Therapeutics, Inc. 13F 2024NMRA 13F 2024: institutional holdings for fiscal 2024
• Neumora Therapeutics, Inc. 13F 2023NMRA 13F 2023: institutional holdings for fiscal 2023
• Neumora Therapeutics, Inc. 13F 2022NMRA 13F 2022: institutional holdings for fiscal 2022

More companies